Multi drug resistance and Extended Spectrum Beta Lactamases in clinical isolates of Shigella: A study from New Delhi, India
- 1 July 2016
- journal article
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 14 (4) , 407-413
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Rapid Emergence of Third-Generation Cephalosporin Resistance in Shigella Sp. Isolated in Andaman and Nicobar Islands, IndiaMicrobial Drug Resistance, 2011
- Extended spectrum beta-lactamase production in Shigella isolates – A matter of concernIndian Journal of Medical Microbiology, 2011
- The Sudden Dominance of blaCTX–M Harbouring Plasmids in Shigella spp. Circulating in Southern VietnamPLOS Neglected Tropical Diseases, 2010
- Rapid emergence of third generation cephalosporin resistant Shigella spp. in Southern VietnamJournal of Medical Microbiology, 2009
- Widespread Dissemination of Aminoglycoside Resistance Genes armA and rmtB in Klebsiella pneumoniae Isolates in Taiwan Producing CTX-M-Type Extended-Spectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 2009
- Quinolone resistance among Shigella spp. isolated from travellers returning from IndiaClinical Microbiology and Infection, 2008
- Changing Epidemiology of Shigellosis and Emergence of Ciprofloxacin-Resistant Shigellae in IndiaJournal of Clinical Microbiology, 2007
- Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), IndiaEpidemiology and Infection, 2005
- Extended-spectrum β-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in BangladeshJournal of Antimicrobial Chemotherapy, 2004